Today: 13 June 2026
Browse Category

NYSE:QGEN 19 November 2025 - 20 January 2026

Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen shares jumped 15.9% to $55.13 in U.S. trading Tuesday after reports the diagnostics firm is exploring strategic options, including a potential sale, and has hired advisers. Bloomberg said the company’s board is handling new takeover interest, but talks remain preliminary. Qiagen will report fourth-quarter results Feb. 4, with a conference call set for Feb. 5. The company has not commented on the reports.
20 January 2026
··
Inside Deutsche Börse & Frankfurt Stock Exchange: Europe’s Financial Powerhouse Unveiled (2025 Update)

Germany Stock Market Today: DAX Edges Higher but Stays Near Five‑Month Lows – 19 November 2025

Germany’s DAX index hovered near 23,200 on Wednesday, barely above Tuesday’s close and still close to five-month lows after a 1.7% drop. Early gains in Daimler Truck, Siemens Energy, and Qiagen offset weakness in chemicals and autos. Investors focused on upcoming Nvidia earnings and U.S. data. The STOXX 600 slipped 0.2%, tracking global tech-driven declines.
19 November 2025
····

Stock Market Today

  • Caledonia Mining Reports High Grade Motapa Drilling Amid Depressed Shares
    June 13, 2026, 3:48 PM EDT. Caledonia Mining (NYSEAM:CMCL) announced significant high grade gold drilling results from its 2025 exploration at Motapa, Zimbabwe, revealing continuous mineralised zones near the Bilboes Gold Project. This proximity offers potential operational synergies and shared infrastructure, with a maiden resource estimate pending to clarify Motapa's role in Caledonia's production plans. Despite this, shares trade at $20.18, down 18.5% in the last month and 23.4% year-to-date, and currently about 53% below the $42.73 analyst target price. Investors should monitor the upcoming resource estimate and integration efforts between Motapa and Bilboes, noting execution risks in permitting and development remain. The stock is also estimated to trade nearly 24% below fair value, suggesting a discounted entry point amid mixed market sentiment.

Latest articles

KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools

KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools

13 June 2026
KLA soared 5.55% to $254.54 on its first split-adjusted day after a 10-for-1 stock split and analyst price target hikes tied to AI-driven chip equipment demand, but with the stock now above several split-adjusted targets, investors face heightened risk ahead of the fiscal Q4 report, which will be the next key catalyst for revenue, earnings, and AI-linked demand guidance.
Pfizer trades around $26 with dividend in focus, drug-price worries linger

Pfizer trades around $26 with dividend in focus, drug-price worries linger

13 June 2026
Pfizer closed at $26.21, up 0.15%, outperforming the Health Care Select Sector SPDR ETF despite new German drug-pricing pressures and a European legal setback; investors are focused on the 6.56% dividend yield, reaffirmed 2026 guidance, and pipeline progress in obesity and oncology as Q2 earnings on August 4 approach.
Go toTop